State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 335 actively recruiting studies with Michigan sites out of 335 registered in total. The busiest research areas in Michigan are Endometrial Cancer, Advanced Solid Tumors, Heart Failure. Leading sponsors running trials in the state include University of Michigan, AstraZeneca, SWOG Cancer Research Network. By stage, Michigan trials break down as Phase 1 (66), Phase 2 (101), Phase 3 (90), Phase 4 (14).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 335 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 335. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Endometrial Cancer, Advanced Solid Tumors, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT03767595 N/A
Recruiting
ProACT Post-Approval Study
Condition
Stress Urinary Incontinence
Enrollment
145 pts
Location
United States
Sponsor
Uromedica
NCT01973881 N/A
Recruiting
Quantitative MRI for Myelofibrosis
Condition
Myelofibrosis
Enrollment
192 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT04921865 N/A
Recruiting
Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2...
Condition
Clavicle
Enrollment
76 pts
Location
United States, Austria, Germany
Sponsor
AO Innovation Translation Cent
NCT05938465 Phase 1, Phase 2
Recruiting
Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in ...
Condition
Ileal Pouch
Enrollment
50 pts
Location
United States
Sponsor
Exegi Pharma, LLC
NCT03036319 N/A
Recruiting
Patient-Centered NeuroRehabilitation (PCN)
Condition
Cognitive Deficit
Enrollment
500 pts
Location
United States
Sponsor
University of Michigan
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT06324201 N/A
Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use i...
Condition
Paroxysmal Atrial Fibrillation
Enrollment
250 pts
Location
United States
Sponsor
Heart Rhythm Clinical and Rese
NCT07422675 Phase 1
Recruiting
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Condition
PARKINSON DISEASE (Disorder)
Enrollment
40 pts
Location
United States, Australia
Sponsor
Serina Therapeutics
NCT07533019 Phase 2
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Condition
Vitiligo
Enrollment
66 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
NCT07288398 Phase 3
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Condition
Pulmonary Hypertension Associated With HFpEF
Enrollment
540 pts
Location
United States, Argentina, Austria
Sponsor
Tenax Therapeutics, Inc.
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT06055608 Phase 2
Recruiting
Advancing Transplantation Outcomes in Children
Condition
Kidney Transplant
Enrollment
200 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04228978 N/A
Recruiting
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent...
Condition
Peripheral Artery Disease
Enrollment
212 pts
Location
United States
Sponsor
Northwestern University
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
NCT04812314 N/A
Recruiting
Exercise Effects on Adipose Tissue Structure and Function
Condition
Obesity
Enrollment
46 pts
Location
United States
Sponsor
University of Michigan
NCT07218926 Phase 3
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastr...
Condition
Gastrointestinal Neoplasms
Enrollment
450 pts
Location
United States, Australia, Belgium
Sponsor
GlaxoSmithKline
NCT07507643 Phase 3
Recruiting
A Study of Methylprednisolone in People Having Liver Surgery
Condition
Hepatectomy
Enrollment
750 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07705035 Phase 1
Recruiting
DBC-664 in Adult Patients With Solid Tumors
Condition
Malignant Germ Cell Tumor
Enrollment
210 pts
Location
United States
Sponsor
Duboce Biopharmaceuticals, Inc
NCT06619561 Phase 2
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host ...
Condition
Chronic Graft-Versus-Host Disease (cGVHD)
Enrollment
48 pts
Location
United States
Sponsor
Deciphera Pharmaceuticals, LLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology